Area of research
Molecular Biology · Complementary and alternative medicine
Research interest
Research interests include Angiogenesis and VEGF in Cancer, Cardiovascular and exercise physiology, Cardiac Health and Mental Health, and Mesenchymal stem cell research.
Prevention and rehabilitation after heart transplantation: A clinical consensus statement of the European Association of Preventive Cardiology, Heart Failure Association of the ESC, and the European Cardio Thoracic Transplant Association, a section of ESOT
Toll-like receptor 2, hyaluronan, and neutrophils play a key role in plaque erosion: the OPTICO–ACS study
The Role of NETosis and Complement Activation in COVID-19-Associated Coagulopathies
Rapid Inflammasome Activation Is Attenuated in Post-Myocardial Infarction Monocytes
Propionate attenuates atherosclerosis by immune-dependent regulation of intestinal cholesterol metabolism
Exercise intensity assessment and prescription in cardiovascular rehabilitation and beyond: why and how: a position statement from the Secondary Prevention and Rehabilitation Section of the European Association of Preventive Cardiology
High-Risk Atherosclerosis and Metabolic Phenotype: The Roles of Ectopic Adiposity, Atherogenic Dyslipidemia, and Inflammation
Towards a personalised approach in exercise-based cardiovascular rehabilitation: How can translational research help? A ‘call to action’ from the Section on Secondary Prevention and Cardiac Rehabilitation of the European Association of Preventive Cardiology
Gut Microbiota–Dependent Trimethylamine <i>N</i> -Oxide Predicts Risk of Cardiovascular Events in Patients With Stroke and Is Related to Proinflammatory Monocytes
Age Is Relative—Impact of Donor Age on Induced Pluripotent Stem Cell-Derived Cell Functionality
Increased Expression of miR-483-3p Impairs the Vascular Response to Injury in Type 2 Diabetes
Micro–RNA-126 Reduces the Blood Thrombogenicity in Diabetes Mellitus via Targeting of Tissue Factor
An unbalanced monocyte polarisation in peripheral blood and bone marrow of patients with type 2 diabetes has an impact on microangiopathy